Entrada Therapeutics (TRDA) Operating Margin (2023 - 2026)
Entrada Therapeutics' quarterly Operating Margin came in at 4834.63% in Q1 2026, down 472864.0% year-on-year from N/an in Q1 2025, and down 48.79% quarter-over-quarter from 3249.27% in Q4 2025.
Entrada Therapeutics has reported Operating Margin for 4 years, with the latest figure at 4834.63% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin fell 472864.0% year-over-year to 4834.63%; the trailing twelve-month figure through Mar 2026 stood at 3109.29% (down 311167.0% YoY), and the FY2025 full-year result was 621.13%, down 64344.0% from the prior year.
- Operating Margin for Q1 2026 stood at 4834.63%, down from 3249.27% in the prior quarter.
- The five-year high for Operating Margin was 56.42% in Q2 2024, with the low at 4834.63% in Q1 2026.
- Average Operating Margin over 4 years is 1046.97%, with a median of 89.7% recorded in 2023.
- Year-over-year, Operating Margin soared 14612 bps in 2024 and plunged 472864 bps in 2026.
- Tracing TRDA's Operating Margin over 4 years: stood at 11.72% in 2023, then slumped by 234 bps to 15.69% in 2024, then slumped by 20612 bps to 3249.27% in 2025, then sank by 49 bps to 4834.63% in 2026.
- The last three Operating Margin figures came in at 4834.63% (Q1 2026), 3249.27% (Q4 2025), and 2915.18% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 17.83% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 23.02% |
| 10 | Entrada Therapeutics | 295.78 Mn | 295.78 Mn | - | -4,834.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,834.63% |
| Dec 31, 2025 | -3,249.27% |
| Sep 30, 2025 | -2,915.18% |
| Jun 30, 2025 | -2,402.51% |
| Mar 31, 2025 | -105.99% |
| Dec 31, 2024 | -15.69% |
| Sep 30, 2024 | -110.67% |
| Jun 30, 2024 | 56.42% |
| Mar 31, 2024 | 35.71% |
| Dec 31, 2023 | 11.72% |
| Sep 30, 2023 | 32.04% |
| Jun 30, 2023 | -89.70% |
| Mar 31, 2023 | -22.88% |